Haseltine, William Alan - from United States

ID: 264830
Organization: TBI
Country of meeting: in the year 2015

Profession:
Serves as Founder at Demetrix, Inc. and served as its Chief Executive Officer till February 2019. Dr. Haseltine has been Senior Advisor at Global Virus Network since May 2013. He serves as the Chairman and Chief Executive Officer at Haseltine Associates Ltd. He serves as President of ACCESS Health International, Inc. He served as Special Advisor to the Board of Directors at Codexis, Inc. since June 2005. Dr. Haseltine serves as Advisor of YuanMing Capital. He serves as Advisor of indiGENE Pharmaceuticals, Pvt. Ltd. He has decades of experience in medicine and entrepeneurship with a career spanning HIV biology, cancer and human genomics. He served as Senior Life Sciences Advisor of Presidio Partners.

He was the Founder of BASF Enzymes LLC. He served as an Advisor at Frazier Healthcare Ventures. Dr. Haseltine founded seven biotechnology companies including Human Genome Sciences Inc., Verenium Corporation, Dendreon Corp., and Diversa Corp. He was a Senior Life Sciences Advisor at CMEA Capital untill 2008. Dr. Haseltine served as an Advisor at Healthcare Ventures LLC where, he participated in the creation of more than 20 other biotech firms, including Medimmune. He served as Chief Executive Officer at Human Genome Sciences Inc. He founded On-Q-ity Inc. in 2004 and served as its Chair of Board of Directors. Dr. Haseltine served as a Consultant from December 1992 until May 1993. He served as the Chairman of the Board at Human Genome Sciences Inc. until October 17, 2004 and its Director since 1993 until October 17, 2004. He serves as Chairman of Advisory Board at Mylan Laboratories Limited.

https://www.bloomberg.com/research/stocks/private/person.asp?personId=206552&privcapId=23565167

Activities in the Orangization:
Honorary Trustee

Back